NCT06996379View on ClinicalTrials.gov

J-Tip Use for Paracentesis in Adults With Liver Cirrhosis and Ascites

NARecruitingINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

May 20, 2025

Primary Completion Date

May 31, 2027

Study Completion Date

May 31, 2027

Conditions
Evaluate Patient Comfort Level During Paracentesis by Numbing Skin With a Needle-less Device, Instead of Using a Needle to Numb the Skin
Interventions
DEVICE

Experimental J-Tip Needle-Free Injection System

This experimental intervention arm will include use of the J-Tip needle-less device to administer a one-time dose of 1% lidocaine during the superficial (intradermal) numbing step of a bedside abdominal paracentesis for adults with cirrhosis of the liver and ascites requiring bedside paracentesis.

DEVICE

Control (Standard treatment)

The control intervention arm will include use of a 25-gauge needle (standard of care) to administer a one-time dose of 1% lidocaine during the superficial (intradermal) numbing step of a bedside abdominal paracentesis for adults with cirrhosis of the liver and ascites requiring bedside paracentesis.

Trial Locations (1)

60611

RECRUITING

Northwestern Memorial Hospital, Chicago

All Listed Sponsors
lead

Northwestern University

OTHER